BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 26298534)

  • 1. The spectrum of posterior reversible encephalopathy in systemic lupus erythematosus.
    Budhoo A; Mody GM
    Clin Rheumatol; 2015 Dec; 34(12):2127-34. PubMed ID: 26298534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Posterior reversible encephalopathy syndrome in Korean patients with systemic lupus erythematosus: risk factors and clinical outcome.
    Jung SM; Moon SJ; Kwok SK; Ju JH; Park KS; Park SH; Kim HY
    Lupus; 2013 Aug; 22(9):885-91. PubMed ID: 23846231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Posterior reversible encephalopathy syndrome in systemic lupus erythematosus.
    Varaprasad IR; Agrawal S; Prabu VN; Rajasekhar L; Kanikannan MA; Narsimulu G
    J Rheumatol; 2011 Aug; 38(8):1607-11. PubMed ID: 21572160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Posterior reversible encephalopathy syndrome in systemic lupus erythematosus.
    Gatla N; Annapureddy N; Sequeira W; Jolly M
    J Clin Rheumatol; 2013 Sep; 19(6):334-40. PubMed ID: 23965484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posterior reversible encephalopathy syndrome and association with systemic lupus erythematosus.
    Ferreira TS; Reis F; Appenzeller S
    Lupus; 2016 Oct; 25(12):1369-76. PubMed ID: 27084028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posterior reversible encephalopathy syndrome--an underrecognized manifestation of systemic lupus erythematosus.
    Kur JK; Esdaile JM
    J Rheumatol; 2006 Nov; 33(11):2178-83. PubMed ID: 16960925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features, outcome, and associated factors for posterior reversible encephalopathy in Thai patients with systemic lupus erythematosus: a case-control study.
    Damrongpipatkul U; Oranratanachai K; Kasitanon N; Wuttiplakorn S; Louthrenoo W
    Clin Rheumatol; 2018 Mar; 37(3):691-702. PubMed ID: 29103182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features, outcomes and risk factors for posterior reversible encephalopathy syndrome in systemic lupus erythematosus: a case-control study.
    Cui HW; Lei RY; Zhang SG; Han LS; Zhang BA
    Lupus; 2019 Jul; 28(8):961-969. PubMed ID: 31208267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic lupus erythematosus complicated with posterior reversible encephalopathy syndrome and intracranial vasculopathy.
    Chen HA; Lin YJ; Chen PC; Chen TY; Lin KC; Cheng HH
    Int J Rheum Dis; 2010 Oct; 13(4):e79-82. PubMed ID: 21199460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes and risk factors for posterior reversible encephalopathy syndrome in systemic lupus erythematosus: a multicentric case-control study.
    Merayo-Chalico J; Apodaca E; Barrera-Vargas A; Alcocer-Varela J; Colunga-Pedraza I; González-Patiño A; Arauz A; Abud-Mendoza C; Martínez-Martínez M; Gómez-Martín D
    J Neurol Neurosurg Psychiatry; 2016 Mar; 87(3):287-94. PubMed ID: 25804426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential serum cytokine profile in patients with systemic lupus erythematosus and posterior reversible encephalopathy syndrome.
    Merayo-Chalico J; Barrera-Vargas A; Juárez-Vega G; Alcocer-Varela J; Arauz A; Gómez-Martín D
    Clin Exp Immunol; 2018 May; 192(2):165-170. PubMed ID: 29271478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features and outcomes of posterior reversible encephalopathy syndrome in patients with systemic lupus erythematosus.
    Lai CC; Chen WS; Chang YS; Wang SH; Huang CJ; Guo WY; Yang WC; Huang DF
    Arthritis Care Res (Hoboken); 2013 Nov; 65(11):1766-74. PubMed ID: 23687067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posterior reversible encephalopathy syndrome could be an underestimated variant of "reversible neurological deficits" in Systemic Lupus Erythematosus.
    Liu B; Zhang X; Zhang FC; Yao Y; Zhou RZ; Xin MM; Wang LQ
    BMC Neurol; 2012 Dec; 12():152. PubMed ID: 23217201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Posterior reversible encephalopathy syndrome in systemic lupus erythematosus: pooled analysis of the literature reviews and report of six new cases.
    Shaharir SS; Remli R; Marwan AA; Said MS; Kong NC
    Lupus; 2013 Apr; 22(5):492-6. PubMed ID: 23435619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posterior reversible encephalopathy syndrome: A neuropsychiatric manifestation of systemic lupus erythematosus.
    Valdez-López M; Aguirre-Aguilar E; Valdés-Ferrer SI; Martínez-Carrillo FM; Arauz A; Barrera-Vargas A; Merayo-Chalico J
    Autoimmun Rev; 2021 Feb; 20(2):102739. PubMed ID: 33326853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posterior reversible encephalopathy syndrome as an initial manifestation of systemic lupus erythematosus.
    Ayas ÖZ; Öcal RÖ; Gundogdu AA
    Ideggyogy Sz; 2017 Nov; 70(11-12):425-427. PubMed ID: 29870651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posterior reversible encephalopathy syndrome: another manifestation of CNS SLE?
    Ishimori ML; Pressman BD; Wallace DJ; Weisman MH
    Lupus; 2007; 16(6):436-43. PubMed ID: 17664235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Posterior reversible encephalopathy syndrome in systemic lupus erythematosus: a case report].
    Zhang XH; Deng XR; Li F; Zhu Y; Zhang ZL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):1102-1107. PubMed ID: 30562790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Posterior reversible encephalopathy syndrome: the importance of its recognition in patients with systemic lupus erythematosus.
    Peixoto D; Teixeira F; Costa JA; Costa L; Araújo D
    Acta Reumatol Port; 2012; 37(2):192-4. PubMed ID: 23149644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of PRES in an active lupus nephritis patient after treatment of corticosteroid and cyclophosphamide.
    Jabrane M; Ait Lahcen Z; Fadili W; Laouad I
    Rheumatol Int; 2015 May; 35(5):935-8. PubMed ID: 25387825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.